Articles Archives - Page 581 of 711

MondayJun 03, 2019 10:22 am

Precision Therapeutics Inc. (NASDAQ: AIPT) Secures Lab Status in NIIMBL Drug Safety Grant, Furthers Aim of Improving Medical Care

The global precision medicine market is expected to reach revenues of over $216.75 billion by 2028, propelled by a growing interest in personalized approaches to disease treatments and the application of new technologies Precision Therapeutics and its three wholly owned subdivisions are advancing the company’s goals of applying artificial intelligence to precision medicine and drug research to improve patient care The company’s Helomics subdivision analyzes disease data, particularly in targeting cancer therapies, and develops applicable technologies; the TumorGenesis division develops tumor-fighting tactics, and the Skyline Medical division markets a device that facilitates biological fluid collection in the medical arena Helomics…

FridayMay 31, 2019 11:49 am

CFO of ChineseInvestors.com Inc.’s (CIIX) Foreign Enterprise to Present at LD Micro Invitational

The CFO of CIIX’s CBD Biotechnology Co. Ltd. is scheduled to speak at the microcap conference The company official is expected to share exciting new developments related to its hemp product line with current and prospective investors The company anticipates exciting opportunities for business growth in the coming months ChineseInvestors.com Inc. (OTCQB: CIIX) will be an official presenter at the 9th Annual LD Micro Invitational to be held June 4-5 at the Luxe Sunset Boulevard Hotel in Bel-Air, California. Alex Hamilton, chief financial officer of CIIX’s wholly owned foreign enterprise, CBD Biotechnology Co. Ltd., will present a corporate overview at…

FridayMay 31, 2019 11:22 am

Spectrum Global Solutions Inc. (SGSI) Provides Full Suite of Telecom Services, Well Positioned for 5G Rollout

SGSI is a leading provider of telecommunications engineering and infrastructure services and solutions The company is ready to meet the growing demand for 5G infrastructure SGSI recently announced multimillion-dollar revenue with positive income Spectrum Global Solutions Inc. (OTCQB: SGSI) is a foremost provider of comprehensive outsourced services and solutions for the deployment and maintenance of next-generation and legacy wireless and wireline telecommunication networks and infrastructure. The company has successfully executed on projects across the United States and globally. Based in Longwood, Florida, Spectrum is professionally registered in 49 states, three U.S. territories (Puerto Rico, the Unites States Virgin Islands and…

FridayMay 31, 2019 10:48 am

Earth Science Tech Inc.’s (ETST) White-Label Initiative Designed to Gain Market Share

The company is now able to fulfill inquiries about white labeling its full-spectrum cannabinoids line ETST has added markets for CBD products through two distribution agreements The company continues to eye product placement in large chain and health food stores, dispensaries, chiropractor offices, athletic clubs and clinics Earth Science Tech Inc. (OTCQB: ETST), a biotech company focused on the nutraceutical and pharmaceutical fields, is seeking to gain more market share through its white-label initiative that offers marketers the ability to rebrand its full-spectrum cannabinoids line (http://ibn.fm/frikT). “I’m excited to share that our sales have consistently increased over 100% every month,” ETST…

FridayMay 31, 2019 10:19 am

MariMed Inc. (MRMD) Reports 69% Jump in Q1 2019 Revenues, Adopts Growth Strategy

MRMD improved its adjusted EBITDA in Q1 2019 by 76 percent The company’s multipronged strategy for growth includes continued consolidation of cannabis operations and the launch of a subsidiary MariMed CEO identified the company as a “significant early mover” in the burgeoning CBD health and wellness market MariMed Inc. (OTCQB: MRMD) recorded a 69 percent jump in revenues to $3,515,815 for the three months ended March 31, 2019, as compared to $2,082,950 for the comparable period of the prior year. The company’s gross profit for the quarter rose 90 percent, to $2,261,025, from $1,194,081 for the same period in 2018.…

FridayMay 31, 2019 9:53 am

Endonovo Therapeutics Inc. (ENDV) to Distribute Non-Invasive, Wearable Therapeutic Devices to Nation’s Veteran Health Care Facilities

Endonovo’s flagship product, SofPulse, is an easy-to-place, non-invasive device delivering pulsed electromagnetic frequencies to enhance post-surgical recovery The company’s agreement with Veterans Healthcare Supply Solutions Inc. includes distribution of SofPulse to Veterans Administration facilities and Department of Defense health care facilities Treatment with SofPulse allows patients to better manage post-operative pain without the adverse side effects of narcotics and anti-inflammatory medications Endonovo holds patents and trademarks for several proprietary technologies and devices Endonovo Therapeutics Inc. (OTCQB: ENDV) is a commercial stage developer of non-invasive medical devices designed to deliver proprietary, patent protected Electroceutical Therapy for the treatment of inflammatory conditions,…

ThursdayMay 30, 2019 11:20 am

Nabis Holdings (CSE: NAB) (OTC: INNPF) (FRA: 71P) Participates in Inaugural Cannabis Forum, Purchases Facility in Washington

Nabis Holdings discussed the importance of cannabis legislative changes during an inaugural edition of a congressional cannabis forum in Washington, DC The company also announced the acquisition of a cannabis extraction and production facility in Washington state Through modernization and expansion, the company plans to ramp up the facility’s production capacity to 20,500 kilograms per year Jade Green, special advisor to Nabis Holdings (CSE: NAB) (OTC: INNPF) (FRA: 71P), participated in the KCSA Strategic Communications’ Inaugural Congressional Cannabis Day Forum that took place in Washington, DC on May 21, 2019. Green attended a panel discussing important legislative changes such as…

ThursdayMay 30, 2019 10:52 am

Geyser Brands Inc. (TSX.V: GYSR) Expands Production Facility, Hopes to Capitalize on CBD Wellness Markets

Geyser Brands recently commenced upgrades; it anticipates R&D and processing amendments The facility expansion is expected to improve the company’s focus on processing quality and consumer satisfaction Solace Management Group recently increased its production capacity and invested in new equipment for consumer health care and pet wellness production Geyser Brands Inc. (TSX.V: GYSR) is a leading Vancouver-based consumer health care company producing some of the world’s most popular cannabis brands and products. The company’s licensed producer (LP), Apothecary Botanicals, has received Health Canada license amendment approval to update its 7,000-square-foot facility located in Port Coquitlam, British Columbia. This expansion, anticipated…

ThursdayMay 30, 2019 10:25 am

Endonovo Therapeutics Inc. (ENDV) is “One to Watch”

Long-term agreement signed with Veterans Healthcare Supply Solutions Inc. to directly distribute SofPulse devices to Veterans Administration Facilities and Department of Defense Healthcare Facilities Partnership with SunMED Medical Solutions, one of the premier medical equipment distributors and claim experts in the U.S., expands Endonovo’s distribution capabilities and expands ability of providers, facilities and patients to seek medical insurance reimbursement Holds 27 patents and numerous trademarks for several proprietary technologies and devices Agreement signed with national recognized hospital for use of SofPulse devices for wound healing and pain management Nationwide network of independent sales representatives and distributors Endonovo Therapeutics Inc. (OTCQB:…

ThursdayMay 30, 2019 10:01 am

INmune Bio Inc. (NASDAQ: INMB) Developing Novel Immunotherapies Targeting Alzheimer’s Disease, Cancer

INmune Bio is a diversified, clinical stage immunology company developing novel therapies targeting distinct parts of a patient’s innate immune system to fight disease Drug candidates INKmune and INB03 may be used to treat cancer; XPro1595 targets neuroinflammation as a cause of Alzheimer’s disease The company was awarded a $1 million “Part the Cloud” grant from the Alzheimer’s Association to advance XPro1595 research INmune recently entered a common stock purchase agreement for up to $20 million with Lincoln Park Capital INmune Bio Inc. (NASDAQ: INMB), an immunology company focused on developing treatments that harness the patient’s innate immune system to…

Site Search

Company Search

Category: Articles